A Study of Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy
Clinical trial NCT05432622 · COMPLETED
Trial details
- NCT number
- NCT05432622
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-12-19
- Primary completion
- 2023-04-26
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.